NEOBE THERAPEUTICS LTD

Active Cambridge

Research and experimental development on biotechnology

6 employees website.com
Life sciences and medical technology Research and experimental development on biotechnology
N

NEOBE THERAPEUTICS LTD

Research and experimental development on biotechnology

Founded 20 Jan 2021 Active Cambridge, United Kingdom 6 employees website.com
Life sciences and medical technology Research and experimental development on biotechnology
Accounts Submitted 29 Aug 2025 Next due 30 Sept 2026 5 months remaining
Confirmation Submitted 3 Feb 2026 Next due 3 Feb 2027 9 months remaining
Net assets £694K £437K 2024 year on year
Total assets £831K £351K 2024 year on year
Total Liabilities £137K £87K 2024 year on year
Charges None No charges registered

Contact & Details

Contact

Registered Address

Salisbury House Station Road Cambridge CB1 2LA United Kingdom

Website

www.example.com

Full company profile for NEOBE THERAPEUTICS LTD (13146056), an active life sciences and medical technology company based in Cambridge, United Kingdom. Incorporated 20 Jan 2021. Research and experimental development on biotechnology. View financials, directors, shareholders, and filings.

Business Summary

This company specializes in providing innovative solutions and services across multiple sectors.

Products & Services

consulting software analytics integration

Reports

Credit Report

In-depth credit score, financial analysis, risk assessment and company intelligence.

Financials

Financials

Period 1 Jan → 31 Dec 2024
Type Total Exemption Full
Next accounts 31 December 2025
Due by 30 September 2026 9 months

Net Assets, Total Assets & Total Liabilities (2021–2024)

Cash in Bank

£440.33k

Decreased by £597.01k (-58%)

Net Assets

£693.50k

Decreased by £437.22k (-39%)

Total Liabilities

£137.06k

Increased by £86.57k (+171%)

Turnover

N/A

Employees

6

Increased by 1 (+20%)

Debt Ratio

17%

Increased by 13 (+325%)

Financial History

Revenue, profit, EBITDA and key financial figures

2024
Dec Year End
2023
Dec Year End
P&L
Revenue
£142.3M
£128.7M
Gross Profit
£48.2M
£43.1M
Operating Profit
£22.4M
£19.8M
Net Profit
£18.1M
£15.9M
EBITDA
£31.5M
£28.2M
Assets
Cash
£24.7M
£21.3M
Total Assets
£89.4M
£82.1M
Liabilities
Total Liabilities
£45.2M
£41.8M
Key Metrics
Employees
1,247
1,156
Latest Revenue
£142.3M
Latest EBITDA
£31.5M
Cash Position
£24.7M

Funding

Fundraising & Grants

Funding Rounds 3
Grants 1

Investors (6)

Investor NameInvestor SinceParticipating Rounds
Investor 1Nov 2022Seed
Investor 2Nov 2022Seed
Investor 4Feb 2024Seed

Share Capital

Share Capital

Share allotments and capital structure

4 Allotments 65,971 Shares £1.41m Total
Date FromShare ClassShares AllottedAmount RaisedPrice/Share
22 Dec 202350,436£1.16m£23
22 Dec 20239,317£150k£16.1
11 Jan 20235,218£100k£19.16
14 May 20211,000£0£0

Officers

Officers

2 active 1 resigned
Status
Julie WolfDirectorAmericanUnited States4520 Dec 2023Active
Keith Stuart BlundyDirectorBritishEngland6615 Mar 2023Active

Shareholders

Shareholders (15)

Dr. Pedro Vaz De Almada Correa De Sampaio
22.1%
40,000
Annelise Soulier
22.1%
40,000

Persons with Significant Control

Persons with Significant Control (0)

0 Active 2 Ceased

Annelise Juliette Soulier

Ceased 21 Jan 2024

Ceased

Pedro Vaz De Almada Correa De Sampaio

Ceased 21 Jan 2024

Ceased

Group Structure

Group Structure

No group structure identified

Charges

Charges

No charges registered

Properties

Properties

0 total

No related properties

Documents

Company Filings

DateCategoryDescriptionDocument
3 Feb 2026Confirmation StatementConfirmation statement made on 20 Jan 2026 with updates
30 Jan 2026OfficersChange to director Julie Wolf on 19 Jan 2026
19 Dec 2025OfficersTermination of Laura Margaret Fletcher as director on 19 Dec 2025
19 Dec 2025OfficersAppointment of Deep Science Ventures Limited as director on 19 Dec 2025
29 Aug 2025AccountsAnnual accounts made up to 31 Dec 2024
3 Feb 2026 Confirmation Statement

Confirmation statement made on 20 Jan 2026 with updates

30 Jan 2026 Officers

Change to director Julie Wolf on 19 Jan 2026

19 Dec 2025 Officers

Termination of Laura Margaret Fletcher as director on 19 Dec 2025

19 Dec 2025 Officers

Appointment of Deep Science Ventures Limited as director on 19 Dec 2025

29 Aug 2025 Accounts

Annual accounts made up to 31 Dec 2024

Recent Activity

Latest Activity

Confirmation statement made on 20 Jan 2026 with updates

2 months ago on 3 Feb 2026

Change to director Julie Wolf on 19 Jan 2026

2 months ago on 30 Jan 2026

Termination of Laura Margaret Fletcher as director on 19 Dec 2025

4 months ago on 19 Dec 2025

Appointment of Deep Science Ventures Limited as director on 19 Dec 2025

4 months ago on 19 Dec 2025

Annual accounts made up to 31 Dec 2024

8 months ago on 29 Aug 2025